|3Jun 11, 8:37 PM ET

Atlas Venture Associates Opportunity I, LLC 3

3 · Generation Bio Co. · Filed Jun 11, 2020

Insider Transaction Report

Form 3
Period: 2020-06-11
Holdings
  • Common Stock

    2,590,726
  • Series A Preferred Stock

    Common Stock (8,521,213 underlying)
  • Series C Preferred Stock

    Common Stock (1,518,819 underlying)
Footnotes (4)
  • [F1]The shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. Each of AVA X LP and AVA X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of its pecuniary interest therein, if any.
  • [F2]The Series A Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
  • [F3]The Series C Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
  • [F4]The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any.

Documents

1 file
  • 3
    doc3.xmlPrimary

    FORM 3 SUBMISSION